Progress, and Applications
of the Human Genome Project
Sponsored by the U.S. Department of Energy Human Genome Program
Human Genome News Archive Edition
Several speakers discussed ongoing work in constructing genomic reagents and technologies critical for mapping, gene finding, sequencing, expression studies, and molecular cytogenetics. NLGLP. Larry Deaven (LANL) and Jeff Gingrich (LLNL) announced the successful completion of NLGLP Phase II; libraries are now available for each chromosome, with 40-kb inserts in cosmids and 10-kb inserts in lambda vectors. Lambda clones are distributed through the American Type Culture Collection in Rockville, Maryland. Cosmid arrays, which have been available on a limited basis, soon will be released nonexclusively to industry to establish screening and clone-distribution services for the entire scientific community. Keeping up with demand for library copies has been difficult, Deaven noted, and the national laboratories are now seeking to share distribution with private-sector companies. LANL also completed YAC libraries with an average insert size of about 200 kb for some chromosomes, and both laboratories are exploring use of PAC and BAC vectors. [Library information (http://bbrp.llnl.gov/bbrp/genome/genome.html).]
BACs have been used to form contigs covering a number of regions of interest and to fill holes in YAC maps. Extensive contigs have been formed over multimegabase regions on chromosome 22; eventually, these will provide excellent substrates for sequencing chromosomes. Hundreds of cDNA, Alu-PCR, and STS probes have been used to interrogate the BAC library by hybridization and pooled PCR. All of them have successfully generated appropriate BAC contigs that can be used in gene finding and chromosome mapping.
Simon encouraged researchers to send him problem chromosome segments. Copies of a human PAC library with average insert size of 120 kb and 3x coverage have been distributed to more than 30 genome centers in North America and Europe and to commercial screening companies, including Genome Systems. A stable PAC contig has been prepared for the spinal muscular atrophy region.
Jean-Michel Vos (University of North Carolina, Chapel Hill) described a novel system to clone DNA in human cells as human artificial episomal chromosomes (HAECs) with average insert size 150 to 200 kb for mapping and sequencing and functional studies of large mammalian DNA regions. He presented data on a recently published HAEC-based human genomic library.
David Barker (Molecular Dynamics) spoke about his group's capillary-array electrophoresis instrumentation for high-throughput DNA analysis using confocal fluorescence detection. Fragments are labeled with thiazole orange and run in eight groups of six capillaries with a replaceable hydroxyethylcellulose matrix. Total run time from sample injection to fragment resolution (up to 2 kb) is 20 to 30 min, with single-bp resolution of double-stranded restriction fragments, PCR products over 100 to 400 bp, and a total size range of 50 bp to 12 kb. Applications include mapping, sequencing, and disease diagnostics.
Another promising technique for sizing DNA fragments is single-molecule detection of a fluorescently labeled sample in a flowing stream intersected by a laser beam. Jeffrey Petty (LANL) described early results with this method for sizing larger (2- to 150-kb) DNA fragments more rapidly and accurately than is now possible using gel electrophoresis. (Fragment sizes are inferred from the fluorescence intensity of samples stained with thiazole orange.) Petty also reported progress in detecting signals from individual nucleotides; the group is working to extend the technique for rapidly sequencing 40-kb or larger DNA fragments at a rate of 100 to 1000 bases/s. This technology is being developed under the first (1991) Cooperative and Research Development Agreement (CRADA) between a DOE human genome center and a private company. John Harding leads the research group at GIBCO BRL.
Robert Lipshutz (Affymetrix) discussed applications of high-density oligonucleotide arrays (DNA probe arrays) to screen and physically map cosmid clones into contigs and to detect mutations for clinical diagnosis. For mapping applications, a fluorescently labeled target from a clone (a four-base sequence adjacent to a restriction site) is hybridized to a chip containing spatially arranged probes; this generates a pattern corresponding to a unique marker subset in the clone. Overlapping clones are detected by corre-lating hybridization patterns. Scanner instrumentation for commercial use is being developed by Molecular Dynamics and Hewlett Packard.
Maynard Olson [University of Washington, Seattle (UWS)] noted the importance of automating production of high-accuracy and -resolution restriction maps as a front end for genomic sequencing. He emphasized the need for substantially eliminating stepwise human decision making to achieve major throughput increases and meet Human Genome Project goals.
Return to DOE Contractor-Grantee Introductory Page
Return to Table of Contents
The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v6n5).
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Document Use and Credits
Publications and webpages on this site were created by the U.S. Department of Energy Genome Program's Biological and Environmental Research Information System (BERIS). Permission to use these documents is not needed, but please credit the U.S. Department of Energy Genome Programs and provide the website http://genomics.energy.gov. All other materials were provided by third parties and not created by the U.S. Department of Energy. You must contact the person listed in the citation before using those documents.
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research, Human Genome Program